Teladoc Health, Inc. TDOC
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 605.10M | 606.93M | 613.85M | 642.27M | 626.44M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 605.10M | 606.93M | 613.85M | 642.27M | 626.44M |
| Cost of Revenue | 190.26M | 190.84M | 197.53M | 197.05M | 187.18M |
| Gross Profit | 414.84M | 416.09M | 416.32M | 445.22M | 439.26M |
| SG&A Expenses | 280.96M | 296.82M | 304.90M | 305.74M | 318.78M |
| Depreciation & Amortization | 90.47M | 90.91M | 92.29M | 94.84M | 88.37M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 627.23M | 641.43M | 662.57M | 669.24M | 661.90M |
| Operating Income | -22.13M | -34.50M | -48.73M | -26.97M | -35.46M |
| Income Before Tax | -26.28M | -37.91M | -60.84M | -33.62M | -50.22M |
| Income Tax Expenses | 655.00K | 997.00K | 3.00M | -8.48M | -715.00K |
| Earnings from Continuing Operations | -26.93M | -38.91M | -63.84M | -25.14M | -49.51M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.93M | -38.91M | -63.84M | -25.14M | -49.51M |
| EBIT | -22.13M | -34.50M | -48.73M | -26.97M | -35.46M |
| EBITDA | 31.66M | 19.73M | 5.48M | 28.67M | 10.68M |
| EPS Basic | -0.15 | -0.21 | -0.36 | -0.14 | -0.28 |
| Normalized Basic EPS | -0.07 | -0.12 | -0.17 | -0.09 | -0.12 |
| EPS Diluted | -0.15 | -0.21 | -0.36 | -0.14 | -0.28 |
| Normalized Diluted EPS | -0.07 | -0.12 | -0.17 | -0.09 | -0.12 |
| Average Basic Shares Outstanding | 181.88M | 181.03M | 179.12M | 177.83M | 176.93M |
| Average Diluted Shares Outstanding | 181.88M | 181.03M | 179.12M | 177.83M | 176.93M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |